The Sickle Cell Disease Regional Quality Care Program (SoRCE-Q) - Needs Addressed: In the Midwestern region (Indiana, Illinois, Kentucky, Michigan, Minnesota, North Dakota, Ohio, South Dakota and Wisconsin), the needs of pediatric and adult patients with sickle cell disease (SCD) are great and currently unmet, including: 1) a paucity of knowledgeable providers to care for patients across the lifespan, particularly adults; 2) limited access to comprehensive SCD care teams, especially in rural areas; 3) lack of providers trained in evidence-based guidelines 4) inadequate transition planning for adolescents; 5) underutilization of hydroxyurea and other disease-modifying therapies; 6) behavioral health needs and 7) transportation challenges in some states.. Proposed Services: Since 2014, the Cincinnati Comprehensive Sickle Cell Center at Cincinnati Children’s Hospital Medical Center, has coordinated the Sickle Treatment and Outcomes Research in the Midwest (STORM) regional sickle cell network as part of a HRSA Sickle Cell Treatment Demonstration Project. STORM consists of 11 well-qualified SCD clinics from Indiana (2), Illinois (2), Kentucky, Michigan, Minnesota, North Dakota and Ohio that will partner with 11 community-based organizations (CBO) to create Clinical Community Spokes (CCSs). South Dakota and Wisconsin are clinical affiliates, without a CBO. The goals of STORM are to leverage a sustainable, synergistic network to expand access and improve quality of care, and track quality of life indicators. By August 31, 2030, STORM will serve at least 30% of people in the Midwest; increase eligible people receiving disease-modifying therapies and collect annual data on quality of care with emergency department utilization and quality of life with high school graduation rates. STORM will use QI methodology and data collection on the regional population entered into GRNDaD (Globin Research Network for Data and Discovery) national registry. Priority areas include disease modifying therapies, emergency department utilization and high school graduation rates. STORM sites will collectively develop regional action plan that will provide a comprehensive overview of SCD needs and services across the Midwest. STORM aims to improve access to provider education about high-quality evidence- based care by continuing our innovative regional virtual telementoring programs, STORM ECHO; Behavioral and Mental Health ECHO; Transition to Adult Care ECHO and Patient Centered Excellence in SCD ECHO, modeled from Project ECHO©. STORM will expand to include Quality Improvement ECHO; Emergency Department ECHO and Disease Modifying Treatment ECHO. STORM will develop clinical support tools and offer other educational opportunities to guide providers in managing SCD with best practices. STORM will engage patients, families and other stakeholders with the formation of a Community Advisory Board. Population Served: The STORM region covers approximately 14,000 individuals with SCD across nine states. Stakeholders include pediatric and adult hematology clinical sites; community-based organizations; patients and family members in the Midwest. STORM will partner with the Sickle Cell Disease Hemoglobinopathy National Coordinating Center and other regional HRSA Sickle Cell Disease Regional Care Excellence (SoRCE) grantees.